7701
Fiscal year ends March Quarters are offset from the calendar — Q1 is Apr–Jun

Shimadzu Corporation is a diversified technology group operating across five business segments: measuring instruments, medical equipment, industrial equipment, aviation equipment, and other services. In measuring instruments, the company develops and sells chromatography, mass spectrometry, optical, thermal, X-ray, and electron beam analysis systems, along with water quality monitoring, material testing, and high-speed video cameras. Its medical equipment segment includes angiography systems, X-ray TV systems, general radiography, PET systems, near-infrared cameras, and radiation therapy equipment. The industrial equipment division manufactures turbo molecular pumps, hydraulic gear pumps, control valves, industrial furnaces, helium leak detectors, and high-speed sputtering systems. For aviation, the group produces flight control systems, air management systems, cockpit display systems, and engine auxiliary units. The company also engages in real estate leasing, management, and construction flooring through its other services segment. Key subsidiaries include Shimadzu Science, Shimadzu Diagnostics, Shimadzu Medical Systems, Shimadzu Aero Tech, and Shimadzu Precision Instruments Inc. The group serves customers in research, healthcare, industrial manufacturing, and aerospace sectors across global markets, with specific subsidiaries operating in the United States, Germany, the United Kingdom, China, Korea, Singapore, Malaysia, the United Arab Emirates, and Uruguay.

Summarised from the annual report, fiscal year ended Mar 2026

Industry Scientific & Technical Instruments Homepage shimadzu.com
Sector Technology IR page shimadzu.com
Tags
analytical instruments, medical imaging, mass spectrometry, chromatography, industrial pumps, aviation systems, non-destructive testing, radiation therapy, hydraulic systems, real estate services, Shimadzu Science, Shimadzu Diagnostics, Shimadzu Rika, Shimadzu System Solutions, Shimadzu A-Tech, Shimadzu Scientific Instruments Inc., Shimadzu USA Manufacturing Inc., Shimadzu Europe GmbH, Kleitos Analytical Limited, Shimadzu (Hong Kong) Limited, Shimadzu Enterprise Management (China) Co. Ltd., Shimadzu Instruments (Suzhou) Co. Ltd., Shimadzu Scientific Korea Corporation, Shimadzu (Asia Pacific) Private Limited, Shimadzu Manufacturing Asia SDN BHD, Shimadzu Middle East and Africa FZE, Shimadzu Latin America S.A., Shimadzu Access, Shimadzu Techno Research, Shimadzu Research Laboratory (Europe) Limited, Shimane Shimadzu, Shimadzu Precision Instruments Inc., Beijing Shimadzu Medical Devices Co. Ltd., Shimadzu Medical Systems, Shimadzu Sangi Systems, Shimadzu Precision Technology, Tianjin Shimadzu Hydraulic Co. Ltd., Shimadzu Aero Tech, Shimadzu General Service, Taihei Kogyo
Press page shimadzu.com/med/news

Metrics

Valuation  
Market cap ¥ 1.19T
Market cap (USD) $ 7.435B
P/E 17.82
PEG 3.47
P/BV 2.05
P/S 2.03
P/OCF 19.09
P/FCF 31.24
Dividend yield 1.7%
Turnover / mcap —
Returns  
ROE 11.4%
ROI 9.5%
ROIC 8.6%
Profit margin 10.8%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) 5.1%
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 15
Quality score 22.2%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Revenue 560.728B 539.047B 511.895B 482.24B 428.175B 393.499B 385.443B 391.213B 376.53B 342.479B 342.236B 314.702B 307.532B 264.048B
Net profit 60.499B 53.776B 57.037B 52.048B 47.289B 36.097B 31.766B 32.523B 29.838B 26.473B 23.899B 18.445B 9.724B 7.578B
Free cash flow 39.737B 36.9B 14.625B 31.465B 53.236B 50.489B 23.641B 8.67B 29.243B 18.595B 21.015B — — —

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Share price 3.686K 3.73K 4.237K 4.137K 4.236K 4.007K 2.844K 3.202K 2.989K 1.768K 1.765K 1.34K 916.27 670.64
Price performance 12m -0.01 -0.12 0.02 -0.02 0.06 0.41 -0.11 0.07 0.69 0 0.32 0.46 0.37 —

Filed figures

Figure Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Balance sheet detail
Trade receivables (JPY) 113B 119B 126B 120B 118B 243B 262B 289B 297B 311B
↳ YoY growth +7.1% +5.5% +6.1% -5.1% -1.7% +106.5% +7.7% +10.2% +2.8% +4.8%
↳ 5y CAGR +2.3% +16.6% +17.1% +18.0% +19.9% +21.4%
Borrowings, current (JPY) 2.96B 3.14B 17.3B 2.08B 1.46B 1.5B 1.4B 1.55B 1.37B —
Borrowings, non-current (JPY) 15.6B 15.5B 247M 30M 281M 205M 132M 66M 4M —
Bonds payable (JPY) 15B 15B 15B — — — — — — —
Lease liabilities (JPY) 2.77B 3.05B 3.49B 5.52B 8.51B 9.88B 9.74B 10.3B 10.4B 10.5B
Cash and deposits (JPY) 56.7B 76.9B 73.6B 70.9B 113B 158B 159B 165B 143B 167B
Intangible assets (JPY) 8.4B 9.23B 10.8B 11.4B 11.6B 11.2B 17B 18B 23.7B 23.9B
Net debt (borrowings + leases - cash) (JPY) -35.3B -55.2B -52.6B -63.2B -103B -146B -148B -153B -132B —
Cash flow detail
Operating cash flow (JPY) 29.6B 41.2B 29.5B 39.5B 63.8B 63.4B 48.3B 30.1B 52B 54.7B
Purchases of property, plant and equipment (JPY) -11B -12B -20.8B -15.9B -13.3B -10.1B -16.8B -15.5B -15.1B -14.9B
Change in receivables (cash effect) (JPY) -7.91B -6.91B -6.47B 4.38B -5.44B -220M -1.05B -6.9B -4.39B -1.93B
Change in inventories (cash effect) (JPY) -3.82B -5.51B -2.59B -5.48B 3.13B -5.25B -16.2B -7.18B -4.22B -4.63B
Change in payables (cash effect) (JPY) 5.18B 10B -600M -5.81B -92M 2.26B -4.23B -19.2B -4.3B -9.57B
Dividends paid (cash effect) (JPY) -5.6B -6.19B -7.66B -8.84B -8.84B -11.5B -14.7B -16.5B -18.3B -19.4B
Interest paid (cash effect) (JPY) -138M -139M -124M -103M -180M -188M -281M -293M -262M -304M
Income taxes paid (cash effect) (JPY) -9.18B -8.81B -14.8B -9.31B -10.1B -16.7B -21.8B -23.5B -18.8B -18.4B
Operating cash flow before change in receivables (JPY) 37.5B 48.1B 35.9B 35.1B 69.2B 63.6B 49.4B 37B 56.4B 56.6B
Free cash flow (OCF - PPE - intangibles) (JPY) 18.6B 29.2B 8.67B 23.6B 50.5B 53.2B 31.5B 14.6B 36.9B 39.7B
Income detail
Research and development expense (JPY) 9.3B 9.68B 10.1B 10.6B 10.2B 10.3B 11B 12.3B 18.2B 23.4B
↳ 5y CAGR +1.5% +2.0% +2.7% +3.9% +11.4% +18.2%
Total comprehensive income (JPY) 27.8B 33.2B 28.2B 24.3B 51B 57.1B 57B 85.4B 49.2B 86.7B
Comprehensive income to owners (JPY) 27.8B 33.1B 28.2B 24.3B 51B 57.1B 57B 85.4B 49.2B 86.7B
Provision for credit losses (JPY) 250M 364M 399M 247M 377M 119M 178M 50M 64M 265M
Credit cost ratio (credit losses / average receivables) (%) 0.2% 0.3% 0.3% 0.2% 0.3% 0.1% 0.1% 0.0% 0.0% 0.1%
Reported Jun 30, 2017 Jun 28, 2018 Jun 27, 2019 Jun 26, 2020 Jun 28, 2021 Jun 29, 2022 Jun 29, 2023 Jun 27, 2024 Jun 25, 2025 Jun 23, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Prompts

Shimadzu Corporation (ticker 7701), listed in Japan.

Company History

Date Change Detail
Jul 29, 2022 Acquired Acquired Nissui Pharmaceutical Co., Ltd. (EDINET code E00971). Its filings from before the deal are on its own company page, not shown here.

ETFs Holding Shimadzu Corporation

ETF Weight in ETF Shares Market value As of
DWMF 0.39% 5,200 $ 131.692K Jun 30, 2026
NTSI 0.08% 15,800 $ 400.14K Jun 30, 2026
DFAI 0.03% 190,000 $ 5.459M Nov 12, 2026
DFIC 0.03% 158,300 $ 4.548M Nov 12, 2026
DFSI 0.03% 11,800 $ 339.019K Nov 12, 2026
DFAX 0.01% 48,800 $ 1.402M Nov 12, 2026
AVDE 0.01% 90,000 $ 2.487M Nov 16, 2026
AVSD 0.01% 700 $ 19.342K Nov 16, 2026
DXIV 0.00% 200 $ 5,746.09 Nov 12, 2026